While alterations in PDP1 expression or activity typically result in muscle and neurological pathologies, the dysregulation of PDP2 is more associated with liver-specific metabolic disorders, such as non-alcoholic fatty liver disease and insulin resistance (Shannon et al., 2021). This evidence concerns the gene PDP2 and Other metabolic disease.